Faculty profile
Christine Pratt
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $99,610
BRCA2-deficient fibroblasts in tumour promotion
CIHR · 2018 · Nominated PI
- $100,000
The role of NF-kappaB in aberrant mammary progenitor cell function and development of breast cancer in BRCA1/2 mutation-carriers
CIHR · 2015 · Nominated PI
- $156,060
A-CD estrogens as alternatives to Estrogen-based hormone replacement therapy
CIHR · 2012 · Nominated PI
BRCA2-deficient fibroblasts in tumour promotion
Principal investigators: Pratt, Christine M
Keywords: Brca2-Deficient Fibroblasts
The role of NF-kappaB in aberrant mammary progenitor cell function and development of breast cancer in BRCA1/2 mutation-carriers
Principal investigators: Pratt, Christine M
Keywords: Brca1/Basal Cancer; Breast Cancer; Nf-Kappa B Transcription Factor; Stem / Progenitor Cells; Transgenic Mice
A-CD estrogens as alternatives to Estrogen-based hormone replacement therapy
Principal investigators: Pratt, Christine M
Keywords: Estrogen; Menopause; Rat Model; Safety Studies
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.